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†Centro Singular de Investigacioń en Química Biolox́ica e Materiais Moleculares (CIQUS) and Departamento de Química Orgańica,
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ABSTRACT: The cell internalization of designed oligoar-
ginine peptides equipped with six glutamic acid residues
and an anionic pyranine at the N-terminus is triggered
upon addition of a supramolecular host. This host binds
specifically to the pyranine moiety, enabling the complex
to traverse the cell membrane. Interestingly, none of the
components, neither the host nor the guest, are able to
cross the cell membrane on their own.
Recent years have witnessed increased interest in thedevelopment of efficient cell-penetrating molecular trans-
porters.1 Among the different strategies so far developed, those
based on oligoarginine peptides are particularly effective,2,3 and
have led to many biological and biomedical applications.4 An
appealing step forward in this field would be the development of
responsive systems whose cell internalization could be controlled
using an external stimulus. Progress in this direction has been
slow, and essentially limited to the temporary covalent
attachment of negatively charged tails to the oligoarginine
sequence through cleavable linkers. The polyanionic domain
neutralizes the polycationic character of the peptide, thereby
impairing its internalization; however the active cell penetrating
peptide (CPP) is released upon application of a suitable external
trigger, such as hydrogen peroxide,5 UV light,6 or certain tumor-
associated proteases.7 Although this strategy has raised expect-
ations due to its potential biomedical applications,8 relying on the
cleavage of a covalent linker limits the efficiency of the release,
the selectivity of the process, and the reversibility of the switch.
Furthermore, it inevitably leads to the generation of secondary
polyanionic peptides that might have undesired effects. In this
context, the development of stimuli-responsive cell internal-
ization strategies that do not rely on covalent bond-cleavage
reactions represents an appealing goal.
Anion recognition has been a topic of recent attention due to
the essential functions of anions in biological systems.9 Metal
organic self-assembly10 has allowed the generation of many new
anion receptors.11 The application of these structures to
biological systems is limited due to the toxicity of the metals
and the instability of these species in the presence of competing
ligands such as chloride or thiols in the intracellular medium.
Alternatively, organic containers are ideal candidates due to their
high stability and low toxicity.12 However, only a few covalent
cages have been reported that are capable of encapsulating large
anions in water with high affinity, and their biological
applications are unknown.13
Herein we present a novel approach to control the cell uptake
of oligoarginine CPPs based on the formation of a host−guest
supramolecular complex involving an anion recognition process.
The strategy relies on the encapsulation of a negatively charged
pyranine attached to the N-terminus of a peptide containing an
octaarginine CPP. Interestingly, none of the components, the
encapsulating host or the pyranine-peptide guest, are able to
cross cell membranes in meaningful amounts as separate units,
but their association promotes an efficient cellular uptake of both
partners.
This approach was inspired by our recent discovery that the
oligocationic covalent cage 1 (Figure 1) can selectively
encapsulate the dye pyranine (pyr) with nanomolar affinity
(KD ≈ 1.2 nM).14 Considering that such an interaction might
counterbalance the negative charges of the pyranine fluorophore,
we envisioned that it could compensate the presumable transport
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Figure 1. (Left) Concept of the switching strategy: an Arg8 CPP
electrostatically masked by a polyanionic pyranine-Glun domain is
activated by the formation of a supramolecular host−guest complex
between the pyranine and a positively charged polyamine cage (1).
(Right) Structures of pyranine (pyr), and the host cage 1, in which six
N1,N1′-([3,3′-bipyridine]-6,6′-diylbis(methylene))bis(propane-1,3-dia-
mine) edges, sharing the terminal N3 amines at the vertices, form a
tetrahedral cage. Only one edge of the tetrahedron cage is shown for
clarity.
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inhibitory effect of a pyranine-oligoglutamic oligoanion intro-
duced at the N-terminus of an octaarginine CPP.
As illustrated in Figure 1, pyr-Glun-Arg8 peptides might not
cross membranes; however, addition of the cage 1 was
hypothesized to encapsulate the pyranine moiety, partly
compensating the negative charges of the inhibitory Glun linker
and thereby generating a transport-active complex.15
As shown in Scheme 1, the designed peptide shuttles (pyr-
EnR8) contain a oligoanionic domain connected to an
octaarginine CPP through a short and flexible Gly-Gly-Lys
spacer. The anionic pyranine fluorophore (pyr) is attached to the
N-terminus of the composite peptide sequences using a
carboxylate derivative (pyr-CH2CO2H).
The peptide conjugates were assembled following standard
Fmoc solid phase peptide synthesis protocols,16 and the Lys
residue in the spacer was incorporated with its side chain
protected with an orthogonally cleavable Alloc group, so that it
could be selectively removed in the solid phase to introduce
various functionalities,17 such as the tetramethylrhodamine
(TMR) fluorophore (Scheme 1).
In addition to shuttles with 1 and 6 glutamic acids, we also
synthesized control peptides lacking Glu residues (pyr-R8), as
well as a pyr-E6R8 derivative containing the TMR fluorophore
attached to the Lys side chain (pyr-TMR-E6R8). The desired
peptides were purified and characterized by LC-MS, and
obtained in reasonable yields ranging from 15 to 30% (see the
Supporting Information for details).
Having the desired compounds in hand, we analyzed their cell
internalization properties in mammalian Vero cells by taking
advantage of the intrinsic emission properties of the pyranine
dye. Thus, although pyranine (pyr) is not capable of crossing the
cell membrane by itself (Figure 2, left), its modification with an
octaarginine CPP yields a conjugate (pyr-R8) that is efficiently
internalized in Vero cells upon incubation at 5 μM concentration
(Figure 2, right).
As hypothesized, the presence of only one glutamic acid in the
oligoarginine conjugate (pyr-E1R8), led to a significant decrease
in the cellular uptake (Figure 3, left). However, although pyr-
E1R8 was still partially taken up by cells, the introduction of six
glutamic acid residues led to a complete inhibition of the
internalization, as can be deduced from the lack of significant
intracellular emission for the conjugate pyr-E6R8 (Figure 3,
bottom left). Importantly, addition of 1 equiv of the supra-
molecular cage 1 to pyr-E6R8 (5 μM, 30 min at 37 °C), led to a
clear intracellular emission of the pyranine dye, which displays a
similar endosomal localization to that observed for pyr-R8
(Figure 3, right). These results are in agreement with the
proposed hypothesis that the encapsulation of the pyranine by
the positively charged cage 1 leads to a supramolecular assembly
with similar transport properties to those of pyr-R8. Quantifying
the fluorescence at different times confirmed that the internal-
ization rates increase upon addition of the cage to both pyr-E1R8
or pyr-E6R8 (Figure S25).
Considering that previous fluorescence titrations of pyranine
with the cage 1 showed that the pyranine emission is strongly
quenched upon complexation,14 the above results suggest that
the supramolecular complex may disassemble upon internal-
ization. In any case, the cellular imaging results are consistent
with the proposed model, in which the encapsulation of the
pyranine fluorophore by positively charged cage 1 triggers the
translocation of the supramolecular assembly. Importantly, cell
viability assays confirmed that all peptides as well as cage 1 are
essentially noncytotoxic (Figure S27).
In agreement with previous studies of the host−guest
interaction between the cage 1 and the pyranine moiety, a
fluorescence titration of a PBS solution of pyr-E6R8 (1 μM, pH
7.5) with increasing concentration of cage 1 produces a series of
spectra of decreasing emission intensity due to the quenching of
the pyranine fluorophore by the cage (Figure 4, left). Fitting of
the titration curve to a 1:1 binding model (Figure 4, right),18
Scheme 1. Synthesis of Representative Peptide Derivatives
Used in This Study, And Structure of the Control Peptide pyr-
R8
a
aSee the Supporting Information. TMR = 5-carboxytetramethylrhod-
amine.
Figure 2. Fluorescence micrographies of Vero cells after incubation with
5 μM of pyranine (pyr, left), or pyr-R8 (right) in PBS, for 30 min at 37
°C, followed by double washing with PBS, pH 7.5.
Figure 3. Fluorescence micrographies of Vero cells after incubation with
5 μMof the pyranine conjugates in the absence (left) or presence (right)
of 1 equiv of cage 1, after 30 min at 37 °C, and after washing twice with
PBS, pH 7.5. (Top) pyr-E1R8. (Bottom) pyr-E6R8.
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allowed to obtain a KD of approximately 278 nM, 2 orders of
magnitude weaker than that observed for the complex 1/pyr (KD
= 1.2 nM).14 This lower affinity might be beneficial in terms of
favoring reversible encapsulations and the disassembly of the
supramolecular complex after internalization, albeit this
conclusion must be taken with caution owing to the complexity
of the cellular environment.
Although the fluorescence of the pyranine allowed the
preliminary analysis of the cell entrance capability of its CPP
hybrids, the relatively low intensity of its blue emission advised
the incorporation of a secondary probe with better emission
properties (i.e., brighter, and fluorescent at longer wavelengths).
Therefore, we explored the performance of the 5-carboxyte-
tramethylrhodamine derivative pyr-TMR-E6R8, which was
synthesized as shown in Scheme 1.
Gratifyingly, although pyr-TMR-E6R8 doesn’t internalize, as
deduced from the lack of intracellular fluorescence, addition of
the cage 1 promoted a bright red intracellular fluorescence,
emission that was mainly localized in endosomes (Figure 5, top).
This observation is again consistent with an efficient uptake of
the peptide in the presence of the supramolecular cage.
Importantly, the switching can be reproduced in other types of
cells, including A549 human lung carcinoma cells and HeLa,
which provided similar results (Figure S23).
On the other hand, a more detailed analysis using confocal
microscopy and avoiding washing steps, clearly showed that, in
the absence of the cage, the red emission of the TMRwas located
outside of the cells. However, addition of 1 equiv of the host 1 led
to the formation of red fluorescent vesicles inside cells 30 min
after the addition (Figure 5, bottom).
To understand better the role of cage 1 in the cellular
translocation of the complex, we also prepared a 5-carboxyte-
tramethylrhodamine derivative of the cage, TMR-1, demonstrat-
ing that it is possible to carry out a modification of the initial cage
(Figure 6, top).19 Interestingly, the TMR-modified cage (TMR-
1) showed a limited internalization into cells by itself. However,
after the addition of pyr-E6R8 to the medium, we observed the
appearance of intracellular emission, consistent with the
internalization of the TMR-1/pyr-E6R8 complex (Figure 6,
bottom). In agreement with previous results, the emission was
again mainly localized in endosomes, and fully colocalizes with
that of the pyranine from the peptide shuttle (Figure S24).
Therefore, the supramolecular host 1 not only triggers the
activity of the octaarginine as a transporter, but can itself be also
considered as a cargo. Therefore, this system represents an
interesting case of supramolecular symbiosis, in which both
partners, the host 1 and the pyr-E6R8 guest, act synergistically to
yield an efficient supramolecular transporter.
Finally, addition of an excess (over 3 equiv) of pyranine to the
mixture of 1 and pyr-E6R8, before incubation with the cells, led to
an almost complete inhibition of the cell internalization (Figure
S26). This result further confirms that the cellular translocation is
mediated by the proposed host−guest interaction.
In conclusion, we have demonstrated that organic supra-
molecular capsules can be used to regulate cellular uptake. The
success of our strategy depends upon the cancellation of the cell
membrane adhesiveness of an octaarginine transporter through
introduction of an N-terminal polyanionic tether formed by
glutamic acids and an anionic pyranine. Addition of the
supramolecular host relieves the quenching effect of the
polyanion and triggers the cell entrance. This strategy, which
Figure 4. (Left) Fluorescence emission of pyr-E6R8 (thick solid line)
with increasing concentration of cage 1 in PBS buffer pH 7.5, λexc = 380
nm (gray lines). (Right) Emission profile with the best fit to a 1:1 model.
95% Confidence interval plotted in gray.
Figure 5. (Top) Fluorescence micrographies of Vero cells after
incubation with 5 μM pyr-TMR-E6R8 in the absence (left) or presence
(right) of 1 equiv of cage 1, incubations for 30 min at 37 °C, and after
washing twice with PBS, pH 7.5. (Bottom) Confocal micrographies of
Vero cells after incubation with 5 μM pyr-TMR-E6R8 in the absence
(left) or presence (right) of 1 equiv of cage 1, for 30 min at 37 °C,
without washing.
Figure 6. (Top) Synthesis of TMR-1. (Bottom) Fluorescence
micrographies of Vero cells after incubation with 5 μM TMR-1 in the
absence (left) or presence (right) of 1 equiv of pyr-E6R8, for 30 min at
37 °C (double washing with PBS, pH 7.5).
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involves an uncommon synergic supramolecular effect, might
find important applications to control the spatial and temporal
release of drugs, dyes or other agents inside cells. Furthermore,
since both components, the cage and the peptide, can be
covalently modified to attach molecules, this methodology might
allow to internalize two different drugs at the same time.
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Universitaria (GRC2013-041 and Centro singular de inves-
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(6) (a) Penas, C.; Sańchez, M. I.; Guerra-Varela, J.; Sanchez, L.;
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